Approval · Notice of Compliance 14825 · 2013
PREMARIN: Notice of Compliance 14825
Issued October 18, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14825
- Date
- October 18, 2013
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Estrogenic hormones
Products in this notice
Medicinal ingredients
- CONJUGATED ESTROGENS 0.3 MG per TAB
- CONJUGATED ESTROGENS 0.625 MG per TAB
- CONJUGATED ESTROGENS 1.25 MG per TAB